Thermo Fisher, KPL Partner on Fluorescent Dyes | GenomeWeb
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and KPL have signed a non-exclusive agreement giving KPL global rights to use Thermo’s DyLight Fluorescent Dyes in combination with KPL’s line of antibodies and proteins.
 
The antibodies and dyes can be used in a variety of life science research applications including fluorescence microscopy, Western blotting, and flow cytometry. KPL said it is expanding its offering of DyLight conjugates later this year using a complete series of DyLight dyes across the visible spectrum.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.